This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abe, N. Articles by Atomi, Y. Search for Related Content PubMed PubMed Citation Articles by Abe, N. Articles by Atomi, Y.

Pancreatic Duct Cell Carcinomas Express High Levels of High Mobility Group I(Y) Proteins

First Department of Surgery [N. A., T. Ma., T. Mo., M. S., Y. A.], Department of Clinical Pathology [T. W., H. U.], and Department of Pathology [Y. F.], Kyorin University School of Medicine, Tokyo 181-8611, Japan; Instituto Nazionale dei Tumori di Napoli, Fondazione Senatore Pascale, 80131 Naples, Italy [G. C.]; and Dipartimento di Medicina Sperimentale e Clinica, Facoltà di Medicina e Chirurgia di Catanzaro, Universita di Reggio Calabria, 88100 Catanzaro, Italy [A. F.]

The high mobility group I (HMGI) family of proteins in mammals belongs to a group of nonhistone nuclear proteins known as architectural transcriptional factors. They function in vivo as both structural components of chromatin and auxiliary gene transcription factors. In an earlier study (N. Abe et al., Cancer Res., 59: 1169–1174, 1999), we demonstrated that the expression level of the HMGI(Y) gene/proteins was significantly increased in colorectal adenocarcinoma and colorectal adenoma with severe cellular atypia. In the current study, we analyzed HMGI(Y) expression in several human pancreatic lesions to investigate (a) whether HMGI(Y) overexpression is also observed in pancreatic carcinoma, and (b) the role of HMGI(Y) in the diagnosis of pancreatic neoplasms. To this end, HMGI(Y) expression was determined at the protein level by immunohistochemistry using a HMGI(Y)-specific antibody in 6 surgically resected specimens of nonneoplastic tissue (4 specimens of normal pancreatic tissue and 2 specimens of chronic pancreatitis tissue), 8 pancreatic cystic neoplasms (5 intraductal papillary mucinous adenomas, 1 serous cystadenoma, and 2 solid pseudopapillary tumors), and 15 duct cell carcinomas of the pancreas. Immunohistochemical analysis revealed intense nuclear staining in the pancreatic carcinoma cells, whereas only very faint nuclear staining was seen in the nonneoplastic cells. There was a strong correlation between HMGI(Y) protein overexpression and a diagnosis of carcinoma (P = 0.000018). Thus, an increased expression level of the HMGI(Y) proteins was clearly associated with the malignant phenotype in pancreatic tissue. In addition, a low level of protein expression was also apparent in two of the cystic neoplasms that exhibited cellular atypia, but not in those that did not exhibit cellular atypia. Based on these findings, we propose that the HMGI(Y) proteins could be closely associated with tumorigenesis in the pancreas and that HMGI(Y) could serve as a potential diagnostic molecular marker for distinguishing pancreatic malignancies unambiguously from normal tissue or benign lesions.

This article has been cited by other articles:

				S.-S. Liau and E. Whang HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma Clin. Cancer Res., March 1, 2008; 14(5): 1470 - 1477. [Abstract] [Full Text] [PDF]

				S. Kolb, R. Fritsch, D. Saur, M. Reichert, R. M. Schmid, and G. Schneider HMGA1 Controls Transcription of Insulin Receptor to Regulate Cyclin D1 Translation in Pancreatic Cancer Cells Cancer Res., May 15, 2007; 67(10): 4679 - 4686. [Abstract] [Full Text] [PDF]

				S.-S. Liau, A. Jazag, and E. E. Whang HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma Cancer Res., December 15, 2006; 66(24): 11613 - 11622. [Abstract] [Full Text] [PDF]

				H. Murua Escobar, J. T. Soller, A. Richter, B. Meyer, S. Winkler, J. Bullerdiek, and I. Nolte "Best Friends" Sharing the HMGA1 Gene: Comparison of the Human and Canine HMGA1 to Orthologous Other Species J. Hered., November 1, 2005; 96(7): 777 - 781. [Abstract] [Full Text] [PDF]

				G. Chiappetta, G. Botti, M. Monaco, R. Pasquinelli, F. Pentimalli, M. Di Bonito, G. D'Aiuto, M. Fedele, R. Iuliano, E. A. Palmieri, et al. HMGA1 Protein Overexpression in Human Breast Carcinomas: Correlation with ErbB2 Expression Clin. Cancer Res., November 15, 2004; 10(22): 7637 - 7644. [Abstract] [Full Text] [PDF]

				X. Chen, J. Lechago, A. Ertan, G. Ergun, R. Verm, M. Bridges, C. Johnson, K. Woods, F. Meriano, M. Chirala, et al. Expression of the High Mobility Group Proteins HMGI(Y) Correlates with Malignant Progression in Barrett's Metaplasia Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 30 - 33. [Abstract] [Full Text] [PDF]

				G. M. Pierantoni, S. Battista, F. Pentimalli, M. Fedele, R. Visone, A. Federico, M. Santoro, G. Viglietto, and A. Fusco A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas Carcinogenesis, December 1, 2003; 24(12): 1861 - 1869. [Abstract] [Full Text] [PDF]

				V. Masciullo, G. Baldassarre, F. Pentimalli, M. T. Berlingieri, A. Boccia, G. Chiappetta, J. Palazzo, G. Manfioletti, V. Giancotti, G. Viglietto, et al. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas Carcinogenesis, July 1, 2003; 24(7): 1191 - 1198. [Abstract] [Full Text] [PDF]

				G. Baldassarre, S. Battista, B. Belletti, S. Thakur, F. Pentimalli, F. Trapasso, M. Fedele, G. Pierantoni, C. M. Croce, and A. Fusco Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma Mol. Cell. Biol., April 1, 2003; 23(7): 2225 - 2238. [Abstract] [Full Text] [PDF]

				P. Finelli, G. M. Pierantoni, D. Giardino, M. Losa, O. Rodeschini, M. Fedele, E. Valtorta, P. Mortini, C. M. Croce, L. Larizza, et al. The High Mobility Group A2 Gene Is Amplified and Overexpressed in Human Prolactinomas Cancer Res., April 1, 2002; 62(8): 2398 - 2405. [Abstract] [Full Text] [PDF]

				N. Takaha, A. L. Hawkins, C. A. Griffin, W. B. Isaacs, and D. S. Coffey High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells Cancer Res., February 1, 2002; 62(3): 647 - 651. [Abstract] [Full Text] [PDF]

				M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco Role of the high mobility group A proteins in human lipomas Carcinogenesis, October 1, 2001; 22(10): 1583 - 1591. [Abstract] [Full Text] [PDF]